Together, with the Alzheimer's Association, we are excited to announce that we are launching the Part the Cloud Gene Targeting Challenge to supercharge the development of therapies tailored to the genetic underpinnings of Alzheimer's disease.

Did you know that more than 100 risk genes have been linked with increased and decreased risk of development of Alzheimer's? These risk genes may influence changes in the brain that differ from person to person, presenting opportunities for personalized gene editing and therapy.

Personalized medicine approaches are the future of treatment for Alzheimer's and other dementia. And we need your support to move as quickly as we can to power the most promising research in this cutting-edge area.

We're calling on our global network of visionary philanthropic partners to join with us by making a high-impact gift for this Challenge. Together, we will fund Alzheimer's research with the highest probability of slowing, stopping or ultimately curing Alzheimer's disease.